Ortivus

Ortivus FCF per Share

The Free Cash Flow per Share of Ortivus (ORTI B.ST) as of Oct 31, 2026 is -0.69 SEK. In the previous year, Free Cash Flow per Share was -0.22 SEK — a change of 214.37% (lower).

FCF per Share

-0.69SEK

YoY

214.37%

Last updated:

Free Cash Flow per Share of Ortivus is 2025 -0.69 SEK. Free Cash Flow per Share of Ortivus was 2024 -0.22 SEK. It decreases by 214.37% lower compared to the previous year.

The Ortivus FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
-0.04 SEK
Jan 1, 2019
-0.10 SEK
Jan 1, 2020
0.36 SEK
Jan 1, 2021
0.02 SEK
Jan 1, 2022
-0.29 SEK
Jan 1, 2023
-0.25 SEK
Jan 1, 2024
-0.22 SEK
Jan 1, 2025
-0.69 SEK
The Ortivus FCF per Share history
YEARFCF per ShareYoY
-0.69SEK+214.37%
-0.22SEK-11.60%
-0.25SEK-14.69%
-0.29SEK-1,309.98%
0.02SEK-93.26%
0.36SEK-475.05%
-0.10SEK+145.58%
-0.04SEK-89.16%
-0.36SEK-341.86%
0.15SEK-134.91%
-0.43SEK-422.17%
0.13SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ortivus Stock analysis

What does Ortivus do? Ortivus AB develops and sells clinical devices and systems, including MobiMed Smart, a decision support system for ambulance personnel to handle documentation, monitoring, and structured prehospital care. CoroNet is a mobile surveillance solution enabling patients to move freely under medical supervision while providing healthcare professionals with real-time monitoring data. The company offers additional services like support, implementation, training, and consulting. Its primary customers are ambulance services and emergency departments. Ortivus AB generates revenue through the sale of MobiMed Smart and CoroNet systems, along with associated services. Ambulance services and emergency departments purchase these products to improve prehospital care documentation and patient monitoring. The decision support system MobiMed Smart streamlines ambulance operations, while CoroNet enhances patient supervision in healthcare settings, addressing key needs for efficient medical response and care management. The company's revenue model relies on direct sales of its clinical systems and supplementary services to healthcare providers. MobiMed Smart targets ambulance personnel for prehospital care documentation, and CoroNet serves healthcare professionals needing mobile patient monitoring. These products are tailored to the specific operational requirements of ambulance services and emergency departments, ensuring alignment with their workflows and care standards. Ortivus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ortivus stock

Free Cash Flow per Share of Ortivus is -0.69 SEK in 2025.

Free Cash Flow per Share of Ortivus changed from -0.22 SEK to -0.69 SEK, representing a 214.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Ortivus since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ortivus

All Key Metrics — Ortivus